BioSig Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioSig Technologies generated cash of -$17,313,000, which is more than the previous year. Cash used in financing activities reached the amount of $17,332,000 last year. Net change in cash is therefore -$167,000.
Cash Flow
| 2014 | -1.99M | -3.96K | 1.93M |
|---|---|---|---|
| 2015 | -4.52M | -18.47K | 5.25M |
| 2016 | -5.10M | -16.25K | 5.22M |
| 2017 | -7.47M | -9.43K | 7.97M |
| 2018 | -10.25M | -307.67K | 13.46M |
| 2019 | -15.48M | -285.93K | 23.42M |
| 2020 | -26.60M | -87K | 42.84M |
| 2021 | -26.39M | -542K | 10.33M |
| 2022 | -21.70M | -168K | 10.57M |
| 2023 | -17.31M | -186K | 17.33M |
BSGM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 357K | 11.65M | 28.26M | 12.10M | 4.45M | 1.54M | 1.05M | 953.23K | 239.78K | 302.18K |
Operating activities | ||||||||||
Net income | -28.69M | -27.26M | -32.85M | -59.14M | -34.47M | -17.25M | -12.69M | -11.58M | -9.46M | -8.47M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 361K | 293K | 198K | 550K | 54.34K | 12.40K | 11.69K | 10.47K | 10.47K | 15.80K |
Stock-based compensation expense | 7.97M | 4.41M | 9.5M | 25.16M | 15.17M | 0 | 4.74M | 5.99M | 7.96M | 5.74M |
| Deferred income tax benefit | 7.97M | 4.41M | 9.5M | 25.16M | 15.17M | 0 | 4.74M | 5.99M | 7.96M | 5.74M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 81K | -9K | 1.98M | -3.23M | -537.49K | 0 | 0 | 0 | 0 | 0 |
Inventories | 1.97M | 284K | -1.11M | -287K | -577.69K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 776 | -1.98M | 3.23M | 537.49K | 478.75K | 102.33K | 149.66K | -333.49K | -110.84K |
Cash generated by operating activities | -17.31M | -21.70M | -26.39M | -26.60M | -15.48M | -10.25M | -7.47M | -5.10M | -4.52M | -1.99M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.61K | 0 |
Investments In Property Plant And Equipment | -186K | -168K | -542K | -87K | -288.68K | -307.67K | -9.43K | -16.25K | -15.86K | -3.96K |
Acquisitions Net | 0 | 0 | 0 | 0 | 2.74K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -186K | -168K | -542K | -87K | -285.93K | -307.67K | -9.43K | -16.25K | -18.47K | -3.96K |
Financing activities | ||||||||||
Common Stock Issued | 15.36M | 10.35M | 10.30M | 27.44M | 10.00M | 9.13M | 6.04M | 5.22M | 4.75M | 1.96M |
Payments for dividends | -9K | -9K | 0 | 0 | -399.59K | 0 | -116.86K | 0 | -2.14M | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.78K |
Cash used in financing activities | 17.33M | 10.57M | 10.33M | 42.84M | 23.42M | 13.46M | 7.97M | 5.22M | 5.25M | 1.93M |
Net Change In Cash | -167K | -11.30M | -16.60M | 16.15M | 7.65M | 2.90M | 491.68K | 102.66K | 713.45K | -62.40K |
Cash at end of period | 190K | 357K | 11.65M | 28.26M | 12.10M | 4.45M | 1.54M | 1.05M | 953.23K | 239.78K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |